Cleared Special

K232605 - Sacrix® Sacroiliac Joint Fusion Device System, Inspan® ScrewLES Fusion System, Invue® MAX™ + Invue Inset Anterior Cervical Plate System, and FacetFuse® Screw Fixation System (FDA 510(k) Clearance)

Sep 2023
Decision
31d
Days
Class 2
Risk

K232605 is an FDA 510(k) clearance for the Sacrix® Sacroiliac Joint Fusion Device System, Inspan® ScrewLES Fusion System, Invue® MAX™ + Invue Inset Anterior Cervical Plate System, and FacetFuse® Screw Fixation System. This device is classified as a Sacroiliac Joint Fixation (Class II - Special Controls, product code OUR).

Submitted by Lesspine Innovations (Malden, US). The FDA issued a Cleared decision on September 28, 2023, 31 days after receiving the submission on August 28, 2023.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3040. Sacroiliac Joint Fusion.

Submission Details

510(k) Number K232605 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 28, 2023
Decision Date September 28, 2023
Days to Decision 31 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code OUR - Sacroiliac Joint Fixation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3040
Definition Sacroiliac Joint Fusion